Monica Seger

975 total citations
24 papers, 718 citations indexed

About

Monica Seger is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health. According to data from OpenAlex, Monica Seger has authored 24 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Psychiatry and Mental health. Recurrent topics in Monica Seger's work include Radiopharmaceutical Chemistry and Applications (7 papers), Prostate Cancer Treatment and Research (6 papers) and Sexual function and dysfunction studies (5 papers). Monica Seger is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Prostate Cancer Treatment and Research (6 papers) and Sexual function and dysfunction studies (5 papers). Monica Seger collaborates with scholars based in United States, Canada and Sweden. Monica Seger's co-authors include H.P.J. Bennett, Gerald Brock, Larry I. Lipshultz, Martin Gleave, Gary Karlin, Harin Padma-Nathan, Ajay Nehra, Peter H. Burbach, J.P.H. Burbach and E. van der Beek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Monica Seger

23 papers receiving 686 citations

Peers

Monica Seger
Simone Granchi Italy
Dennis Earle United States
Michaël Verbiest Netherlands
J Morissette Canada
Mario Pepe Italy
Sofia Jönsson Sweden
P. Hwang Canada
Michael Silver United States
F. W. SELBY United States
Rita Daverio Italy
Simone Granchi Italy
Monica Seger
Citations per year, relative to Monica Seger Monica Seger (= 1×) peers Simone Granchi

Countries citing papers authored by Monica Seger

Since Specialization
Citations

This map shows the geographic impact of Monica Seger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Seger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Seger more than expected).

Fields of papers citing papers by Monica Seger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Seger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Seger. The network helps show where Monica Seger may publish in the future.

Co-authorship network of co-authors of Monica Seger

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Seger. A scholar is included among the top collaborators of Monica Seger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Seger. Monica Seger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seger, Monica. (2022). Toxic Matters. University of Virginia Press eBooks. 3 indexed citations
2.
Heidenreich, Axel, Silke Gillessen, Daniel Heinrich, et al.. (2019). Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. BMC Cancer. 19(1). 12–12. 33 indexed citations
3.
Saad, Fred, Silke Gillessen, Daniel Heinrich, et al.. (2019). Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program. Clinical Genitourinary Cancer. 17(5). 348–355.e5. 23 indexed citations
4.
5.
Morris, Michael J., Yohann Loriot, Karim Fizazi, et al.. (2017). Effects of radium-223 (Ra-223) with docetaxel versus docetaxel alone on bone biomarkers in patients with bone-metastatic castration-resistant prostate cancer (CRPC): A phase I/IIa clinical trial.. Journal of Clinical Oncology. 35(6_suppl). 154–154. 9 indexed citations
6.
Parker, Christopher, Steven E. Finkelstein, Jeff M. Michalski, et al.. (2016). Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial. European Urology. 70(5). 875–883. 51 indexed citations
7.
Saad, Fred, Daniel Keizman, Joe M. O’Sullivan, et al.. (2016). Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP).. Journal of Clinical Oncology. 34(15_suppl). 5082–5082. 23 indexed citations
8.
Seger, Monica. (2015). Landscapes in Between. University of Toronto Press eBooks. 4 indexed citations
9.
Sasaki, Jennifer C., Robert E. Chapin, William J. Breslin, et al.. (2011). Incidence and nature of testicular toxicity findings in pharmaceutical development. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(6). 511–525. 30 indexed citations
10.
Rosen, Raymond C., Ridwan Shabsigh, Pierre Assalian, et al.. (2006). Efficacy and Tolerability of Vardenafil in Men With Mild Depression and Erectile Dysfunction: The Depression-Related Improvement With Vardenafil for Erectile Response Study. American Journal of Psychiatry. 163(1). 79–87. 60 indexed citations
11.
Rosen, Robert, Francesco Montorsi, Pierre Assalian, et al.. (2004). LB14 Efficacy and tolerability of vardenafil in men with mild major depressive disorder and erectile dysfunction: The depression related improvement with vardenafil for erectile response (driver) study. European Urology Supplements. 3(2). 235–235. 8 indexed citations
12.
Brock, Gerald, Ajay Nehra, Larry I. Lipshultz, et al.. (2003). Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy. The Journal of Urology. 170(4 Part 1). 1278–1283. 165 indexed citations
13.
Brock, Gerald, Terry Taylor, & Monica Seger. (2002). Efficacy and tolerability of vardenafil in men with erectile dysfunction following radical prostatectomy. European Urology Supplements. 1(1). 152–152. 33 indexed citations
14.
Seger, Monica, et al.. (1990). The C-terminal glycopeptide of propressophysin potentiates excitatory transmission in the rat lateral septum. Neuroscience. 37(3). 647–653. 10 indexed citations
15.
Leeuwen, Frank N. van, E. van der Beek, Monica Seger, Peter H. Burbach, & Richard Ivell. (1989). Age-related development of a heterozygous phenotype in solitary neurons of the homozygous Brattleboro rat.. Proceedings of the National Academy of Sciences. 86(16). 6417–6420. 64 indexed citations
16.
Seger, Monica, M. Van Eekelen, József Z. Kiss, Peter H. Burbach, & E. R. de Kloet. (1988). Stimulation of Pro-Opiomelanocortin Gene Expression by Glucocorticoids in the Denervated Rat Intermediate Pituitary Gland. Neuroendocrinology. 47(4). 350–357. 27 indexed citations
17.
Seger, Monica, József Z. Kiss, Hubert H.M. Van Tol, & J. Peter H. Burbach. (1987). Biosynthesis of pro-opiomelanocortin is increased in the rat intermediate pituitary following denervation. Neuroscience Letters. 83(1-2). 149–155. 4 indexed citations
18.
19.
Bennett, H.P.J., Patricia L. Brubaker, Monica Seger, & Samuel G. Solomon. (1983). Human phosphoserine 31 corticotropin1-39. Isolation and characterization.. Journal of Biological Chemistry. 258(13). 8108–8112. 31 indexed citations
20.
Boni, Umberto De, Monica Seger, John W. Scott, & D. R. Crapper. (1976). Neuron culture from adult goldfish. Journal of Neurobiology. 7(6). 495–512. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Granchi Breakdown of academic impact, for papers by Dennis Earle Breakdown of academic impact, for papers by Michaël Verbiest Breakdown of academic impact, for papers by J Morissette Breakdown of academic impact, for papers by Mario Pepe Breakdown of academic impact, for papers by Sofia Jönsson Breakdown of academic impact, for papers by P. Hwang Breakdown of academic impact, for papers by Michael Silver Breakdown of academic impact, for papers by F. W. SELBY Breakdown of academic impact, for papers by Rita Daverio
Rankless by CCL
2026